Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRYAN D HARRIS

Allopathic & Osteopathic Physicians Dermatology

NPI
1174553556
CMS profile
325641
Location
LUBBOCK, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,766.88

151 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,766.88 151

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRYAN D HARRIS

NPI 1174553556 · CMS profile ID 325641

Allopathic & Osteopathic Physicians / Dermatology

LUBBOCK, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174553556?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRYAN D HARRIS, NPI 1174553556, CMS profile ID 325641. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174553556?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). BRYAN D HARRIS, NPI 1174553556, CMS profile ID 325641. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174553556?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
BRYAN D HARRIS, NPI 1174553556, CMS profile ID 325641, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1174553556?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

151 matching records · $2,766.88 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 151 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 151.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $33.1308/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228651009 CMS
GENZYME CORPORATION $8.4908/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233308709 CMS
Novartis Pharmaceuticals Corporation $27.2808/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200299858 CMS
Lilly USA, LLC $6.2208/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186547334 CMS
Regeneron Healthcare Solutions, Inc. $14.3308/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212938709 CMS
Janssen Biotech, Inc. $17.0708/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175093335 CMS
Janssen Biotech, Inc. $3.6708/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175096450 CMS
Novartis Pharmaceuticals Corporation $20.4808/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200299854 CMS
UCB, Inc. $16.8208/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420393 CMS
Galderma Laboratories, L.P. $9.5508/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234651510 CMS
ABBVIE INC. $3.6808/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202010685 CMS
Galderma Laboratories, L.P. $13.0007/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234651508 CMS
Almirall LLC $20.2207/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243876400 CMS
GENZYME CORPORATION $23.3407/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233308679 CMS
Janssen Biotech, Inc. $9.6207/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175094654 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $19.7907/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250977695 CMS
Amgen Inc. $3.6207/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227080733 CMS
Regeneron Healthcare Solutions, Inc. $29.9107/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212938707 CMS
Lilly USA, LLC $8.6707/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186546210 CMS
UCB, Inc. $21.0907/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420391 CMS
Incyte Corporation $28.9106/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226050409 CMS
Janssen Biotech, Inc. $20.6106/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175096896 CMS
Janssen Biotech, Inc. $6.5306/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175092715 CMS
GENZYME CORPORATION $27.2006/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233308649 CMS
Paratek Pharmaceuticals, Inc. $19.5306/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181747840 CMS
UCB, Inc. $29.4906/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420389 CMS
UCB, Inc. $139.8006/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420387 CMS
Lilly USA, LLC $27.4006/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186546126 CMS
Amgen Inc. $6.4906/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227080739 CMS
Regeneron Healthcare Solutions, Inc. $22.2405/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212938705 CMS
Galderma Laboratories, L.P. $15.4505/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234651506 CMS
Regeneron Healthcare Solutions, Inc. $89.7805/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212938703 CMS
UCB, Inc. $12.2105/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420385 CMS
Galderma Laboratories, L.P. $16.0205/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234651504 CMS
Janssen Biotech, Inc. $19.3405/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175095530 CMS
ABBVIE INC. $7.9305/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202010683 CMS
GENZYME CORPORATION $19.7905/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233308633 CMS
E.R. Squibb & Sons, L.L.C. $22.9505/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184866383 CMS
Amgen Inc. $6.3005/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227080737 CMS
GENZYME CORPORATION $28.2505/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233308631 CMS
UCB, Inc. $10.4005/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420383 CMS
Galderma Laboratories, L.P. $15.6805/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234651502 CMS
Incyte Corporation $28.9404/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226084087 CMS
Lilly USA, LLC $11.1804/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186486621 CMS
ABBVIE INC. $4.6604/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202010681 CMS
UCB, Inc. $19.8004/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420381 CMS
Regeneron Healthcare Solutions, Inc. $14.6204/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212938701 CMS
UCB, Inc. $7.1704/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224420379 CMS
Janssen Biotech, Inc. $6.5904/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175094699 CMS
ABBVIE INC. $25.2104/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202010679 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,228.38 103
PY2020 $1,470.39 75
PY2021 $1,900.68 82
PY2022 $2,966.28 112
PY2023 $3,306.99 133
PY2024 $2,646.96 127
PY2025 $2,766.88 151

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $54,303.61 4
PY2024 Principal investigator $59,234.09 3
PY2021 Recipient $500.00 1
PY2019 Recipient $430.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Amgen Inc. $13,027.00 08/01/2025 Non-covered Recipient Entity
ELLIGO HEALTH RESEARCH INC
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) No dispute reported 06/30/2026 1246641155
Principal investigator 1 Amgen Inc. $18,696.86 04/24/2025 Non-covered Recipient Entity
ELLIGO HEALTH RESEARCH INC
A Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study With Re-randomization to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO) No dispute reported 06/30/2026 1246641179
Principal investigator 1 Amgen Inc. $10,107.13 01/30/2025 Non-covered Recipient Entity
LONG AND HARRIS DERMATOLOGY
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) No dispute reported 06/30/2026 1246643611
Principal investigator 1 Amgen Inc. $12,472.62 01/27/2025 Non-covered Recipient Entity
LONG AND HARRIS DERMATOLOGY
A Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study With Re-randomization to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO) No dispute reported 06/30/2026 1246643615